clazosentan



clazosentan


SMILES COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO
InChIKey LFWCJABOXHSRGC-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 13
Hydrogen bond donors 3
Rotatable bonds 11
Molecular weight (Da) 577.1


No bioactivity data available.

clazosentan


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.